Cargando…
Nephroprotection by SGLT2i in CKD Patients: May It Be Modulated by Low-Protein Plant-Based Diets?
Sodium-glucose-transporter 2 inhibitors (SGLT2i) are a new class of anti-diabetic drugs that in large trials such as CREDENCE have shown also a reduction of glomerular hyperfiltration and albuminuria in type 2 diabetic patients. Hence, the interest toward SGLT2i is focused toward this potential neph...
Autores principales: | Cupisti, Adamasco, Giannese, Domenico, Moriconi, Diego, D'Alessandro, Claudia, Torreggiani, Massimo, Piccoli, Giorgina B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793896/ https://www.ncbi.nlm.nih.gov/pubmed/33425967 http://dx.doi.org/10.3389/fmed.2020.622593 |
Ejemplares similares
-
Diagnosis, Prevalence and Significance of Obesity in a Cohort of CKD Patients
por: Moriconi, Diego, et al.
Publicado: (2023) -
Mediterranean Dietary Pattern Adjusted for CKD Patients: The MedRen Diet
por: D’Alessandro, Claudia, et al.
Publicado: (2023) -
Prevalence and Correlates of Sarcopenia among Elderly CKD Outpatients on Tertiary Care
por: D’Alessandro, Claudia, et al.
Publicado: (2018) -
Energy Requirement for Elderly CKD Patients
por: D’Alessandro, Claudia, et al.
Publicado: (2021) -
The “phosphorus pyramid”: a visual tool for dietary phosphate management in dialysis and CKD patients
por: D’Alessandro, Claudia, et al.
Publicado: (2015)